Diana Canto-Sims, OD, introduces the second guest of Season 2, Raphael Rostenne, who will be discussing AI-assisted front desk management.
|Articles|September 16, 2020
Learn about mask-associated dry eye
What to do about mask-induced dry eye
Advertisement
Yes, patients’ eyes are feeling more dry while wearing masks during the pandemic. Karen Walsh, BSc(Hons) PGDip MCOptom FIACLE, professional education team leader and clinical scientist at Centre for Ocular Research and Education (CORE) at the University of Waterloo explains mask-associated dry eye (MADE) is happening and how to prevent it. Check out
Advertisement
Related to this article
For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the burden of certain tasks to make for more patient visits.
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs fell for the first time since tracking began.
Maria Sampalis, OD, discusses her implementation of the EHR software Barti in her practice.
Host Hamza Shah, OD, MS, FAAO, is joined by Cory Lappin, OD, MS, FAAO, to discuss dynamic muscle stimulation for dry eye, spurred by a paper on improving blinking in dry eye patients.
Duravyu gained 2.5 letters vs 6.1 with aflibercept at week 52/56, missing noninferiority in a second phase 3 wet AMD trial.
Alcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness.
From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours
2
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
3
Duravyu for wet AMD misses primary end point in phase 3 LUCIA trial
4
FDA approves subcutaneous Enspryng for TED
5